Live Breaking News & Updates on Regenerative endodontics

Stay informed with the latest breaking news from Regenerative endodontics on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Regenerative endodontics and stay connected to the pulse of your community

Sonoma Pharmaceuticals Announces Partnership with Gabriel Science, LLC For Dental Markets

Sonoma Pharmaceuticals Announces Partnership with Gabriel Science, LLC For Dental Markets
Sonoma Pharmaceuticals Announces Partnership with Gabriel Science, LLC For Dental Markets
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, disinfectant use and dermatological conditions, today announced that it has entered into a non-exclusive distribution agreement with Gabriel Science, LLC for the sale of Microcyn Technology products into the dental market and has accepted its first order.
Endocyn, a Microcyn Technology product manufactured by Sonoma, is a biocompatible root canal irrigant that does not stain teeth or restorations. In a study conducted by the Departments of Endodontics and Cell Biology and Anatomy at Louisiana State University School of Dentistry published in the Journal of Endodontics, Regenerative Endodontics, Endocyn demonstrated less cellular toxicity compared to traditional endodontic irrigants such as sodium hypochlorite. The full study can be found here: https://www.sciencedirect.com/science/article/abs/pii/S0099239917310439

Colorado , United-states , Niwot , Louisiana , Georgia , Netherlands , Roermond , Limburg , America , Mark-fontenot , Amy-trombly , Exchange-commission

Sonoma Pharmaceuticals Announces Partnership with Gabriel Science, LLC For Dental Markets

Posted on
8389
Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, disinfectant use and dermatological conditions, today announced that it has entered into a non-exclusive distribution agreement with Gabriel Science, LLC for the sale of Microcyn® Technology products into the dental market and has accepted its first order.
Endocyn®, a Microcyn® Technology product manufactured by Sonoma, is a biocompatible root canal irrigant that does not stain teeth or restorations. In a study conducted by the Departments of Endodontics and Cell Biology and Anatomy at Louisiana State University School of Dentistry published in the Journal of Endodontics, Regenerative Endodontics, Endocyn demonstrated less cellular toxicity compared to traditional endodontic irrigants such as sodium hypochlorite. The full study can be found here: http://www.sciencedirect.com/science/article/abs/pii/S0099239917310439

Colorado , United-states , Niwot , Louisiana , Georgia , Netherlands , Roermond , Limburg , America , Mark-fontenot , Amy-trombly , Exchange-commission